All Type of News
M&As wave to galvanize Korean pharmaceutical industry
With domestic pharmaceutical markets to be affected by the government’s cash reward plan to doctors and pharmacists who refuse to take rebates and instead purchase medicines at lower prices, local leading drug manufac...
Korean medicines deemed inexpensive
A survey of 300 pharmaceutical active ingredients showed that Korean medicines are not expensive by global standards.
The Health Insurance Review & Assessment Service reported on May 19 that overall, prices of gene...
Dong-A moves to build drug plan in India
Dong-A Pharmaceutical Co. plans to build a pharmaceutical manufacturing plant in India
The company has been extensive research in the region for the possible site of producing its Zydena, a treatment for erectile ...
Doctors calls for more rational approach to drug pricing policy
The government needs to conduct drug pricing policy in more careful manner to guarantee the success of so-called positive list system.
In a recent symposium organized by the Korean Medical Association, all panelist...
Boryung to receive PMS certification
Boryung Pharm said on May 20 that its management system has been investigated by the state-run Korea Production Center and will receive a Productivity Management System (PMS) certification for the first time in the lo...
Vaccines make Green Cross No. 1 drugmaker
Green Cross Corporation became the first biggest drug manufacturer in Korea in terms of quarterly revenue, as the outbreak of influenza A boosted demand for seasonal flu vaccines, according to Yakup Shinmoon.
Green...
Doctors’ antipathy over leading drugmakers perplexes salespeople
The Korean Medical Association has recently decided to accept a revised law that punishes doctors for shady deals with drug makers.
Nevertheless, some physicians’ open attitude to prevent the visit of salespeople i...
Plavix sales in April are staggering
Sanofi-Aventis’s blood thinner Plavix posted 45.5 billion won in April this year, down 5.7 percent compared with 48.2 billion won during the same period of last year, according to Ubist.
Other drug makers producing...
Rebate-taking doctors, pharmacists to face punishment
Doctors and pharmacists who receive what are widely known as rebate from pharmaceutical firms in return for prescribing more recommending their products will face a maximum prison term of two years or a fine of up to ...
Whanin buys 6.22% stake in Ildong Pharm
Whanin Pharmaceutical said on May 13 it holds 6.22 percent stake in Ildong Pharmaceutical, increasing suspicions over the latter’s real intention.
Whanin bought 260,000 shares on May 13 in addition to the existing ...
